Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria.

  title={Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria.},
  author={Kaitlyn E Kortright and Benjamin K Chan and Jonathan L. Koff and Paul E. Turner},
  journal={Cell host \& microbe},
  volume={25 2},

Figures and Tables from this paper

Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies

Greater awareness of what obstacles to this success generally or specifically can exist, as documented in this review, should aid in the further development of phage therapy toward wider use.

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

The need for phage as an alternative treatment is obvious in future and phage therapy can be used as reserve treatment, as well as their therapeutic aspects.

The Ecology of Phage Resistance: The Key to Successful Phage Therapy?

Data is compiled from 88 peer-reviewed studies where phage resistance was experimentally observed and linked to a bacterial gene, then assessed these data for patterns to suggest that bacterialphage resistance is diverse, but even well-studied systems are understudied.

Phage therapeutics: from promises to practices and prospectives

The mechanism of bacteriophage treatment that makes it a real solution for multidrug-resistant infectious diseases is highlighted and significant obstacles that need to be addressed are to design better clinical studies that may contribute to the widespread use of phage therapy against multi-drug resistant pathogens.

Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.

It is highlighted that phage therapy may be a promising route in the treatment of infections caused by multidrug-resistant pathogens and that a combined approach has the potential to prolong the life of the current available antimicrobials.

Broadscale phage therapy is unlikely to select for widespread evolution of bacterial resistance to virus infection

It is concluded that broadscale phage therapy efforts are unlikely to produce widespread selection for evolution of bacterial resistance.

Phage Therapy: Consider the Past, Embrace the Future

It is believed that, with the advancement in synthetic biology and delivery technology, phage therapy has broad prospects in the future and its advantages compared with traditional antibiotic therapy.

Can Bacteriophages Replace Antibiotics?

This opinion article tries to place phage therapy in the context of the health care system and state that the use phages for precision treatments will require a seamless chain of events from the patient to the phages therapy laboratory to allow for the immediate application of phages therapeutically.

Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy

This work considers whether phages used to treat the bacterial infection in a patient might specifically evolve to improve treatment, and explores this possibility for four phage properties expected to promote therapeutic success.



Bacteriophages as potential new therapeutics to replace or supplement antibiotics.

Modeling the synergistic elimination of bacteria by phage and the innate immune system.

Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa

It is concluded that phages, such as OMKO1, represent a new approach to phage therapy where bacteriophages exert selection for MDR bacteria to become increasingly sensitive to traditional antibiotics.

Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence

The efficacy of bacteriophage-therapy alone or combined with antibiotics against experimental endocarditis due to Pseudomonas aeruginosa, an archetype of difficult-to-treat infection, is investigated and phage/ciprofloxacin combinations were highly synergistic.

Genetically Engineered Phages: a Review of Advances over the Last Decade

This review highlights advances in techniques used to engineer phages as vehicles for drug delivery and vaccines, as well as for the assembly of new materials, and discusses existing challenges and opportunities.

Aerosol Phage Therapy Efficacy in Burkholderia cepacia Complex Respiratory Infections

Aerosol phage therapy appears to be an effective method for treating highly antibiotic-resistant bacterial respiratory infections, including those caused by BCC bacteria.

Long-circulating bacteriophage as antibacterial agents.

  • C. MerrilB. Biswas S. Adhya
  • Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 1996
A serial-passage technique in mice is developed to select for phage mutants able to remain in the circulatory system for longer periods of time and it is demonstrated that the long-circulating lambda mutants also have greater capability as antibacterial agents than the corresponding parental strain in animals infected with lethal doses of bacteria.

Experimental Phage Therapy against Staphylococcus aureus in Mice

A bacteriophage active against S. aureus, including methicillin-resistant staphylococcal strains, is described, suggesting a potential use of the phage for the control of both local and systemic human S.aureus infections.